Glutargin tablets 0.75 g 30 pcs.

Glutargin is prescribed for the following diseases:

• in the complex therapy of acute and chronic hepatitis;
• cirrhosis;
• hepatic encephalopathy;
• leptospirosis;
• hepatic coma;
• poisoning with drugs and chemicals;
• alcohol poisoning;
• hangover syndrome;
• prevention of alcohol intoxication;
• Pathologies of the hepatobiliary system in late-term pregnant women.

Usually, glutargin in tablet form is prescribed in a dose of 0.25 g 3 times a day, or a single dose of 0.75 g regardless of meals. In more severe cases, the dose can be increased to 8 g per day. The duration of treatment is from 2 to 3 weeks.

Intravenously drip glutargin is used in severe cases (vomiting, impaired consciousness) with hepatitis, alcohol poisoning or late gestosis of pregnant women at a dose of 10 ml per 150-200 ml of 0.9% sodium chloride solution or 5% glucose. With intramuscular administration, the standard dose is 5 ml 2 times a day.

In case of overdose, the following symptoms may occur: discomfort in the stomach area, nausea, chest pain, insomnia, and low blood pressure.

Treatment: symptomatic therapy, taking antihistamines, in severe cases – intravenous administration of glucocorticosteroids.

• hypersensitivity to the components of the drug.
• increased excitability.
• fever.
• impaired kidney filtration function.
• age up to 18 years.

Glutargin solution should not be mixed with other medicinal solutions, except those recommended.

It should be prescribed with great caution to patients with cancer, as glutamate reduces the effect of anticancer drugs, especially vinblastine.

Glutargin may increase the secretion of insulin and growth hormone in patients with endocrine system disorders; this should be taken into account when prescribing the drug.

The active ingredient of the drug is arginine glutamate.

Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children.